{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:33:41Z","timestamp":1793223221472,"version":"4.5.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Asthma is a respiratory disease that currently affects around 300 million people worldwide and is defined by coughing, shortness of breath, wheezing, mucus overproduction, chest tightness, and expiratory airflow limitation. Increased levels of interleukin 17 (IL-17) have been observed in sputum, nasal and bronchial biopsies, and serum of patients with asthma compared to healthy controls. Patients with higher levels of IL-17 have a more severe asthma phenotype. Biologics are available for T helper 2 (Th2)-high asthmatics, but the Th17-high subpopulation has a relatively low response to these treatments, rendering it a rather severe asthma phenotype to treat. Several experimental models suggest that targeting the IL-17 pathway may be beneficial in asthma. Moreover, as increased activation of the Th17\/IL-17 axis is correlated with reduced inhaled corticosteroids (ICS) sensitivity, targeting the IL-17 pathway might reverse ICS unresponsiveness. In this review, we present and discuss the current knowledge on the role of IL-17 in asthma and its interaction with the Th2 pathway, focusing on the rationale for therapeutic targeting of the IL-17 pathway.<\/jats:p>","DOI":"10.3389\/falgy.2021.694514","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T15:31:49Z","timestamp":1630683109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacological Rationale for Targeting IL-17 in Asthma"],"prefix":"10.3389","volume":"2","author":[{"given":"Siti Farah","family":"Rahmawati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"te Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A. M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S. S.","family":"D\u00f6mling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Robert","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinoud","family":"Gosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"B1","first-page":"94","volume-title":"Global Strategy for Asthma Management and Prevention Updated 2020","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity."},{"key":"B5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.12382","article-title":"Asthma phenotyping: A necessity for improved therapeutic precision and new targeted therapies","volume":"279","author":"Chung","year":"2016","journal-title":"J Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI121087","article-title":"An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup","volume":"129","author":"Christenson","year":"2019","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1067\/mai.2001.117929","article-title":"IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines","volume":"108","author":"Molet","year":"2001","journal-title":"J Allergy Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1067\/mai.2003.1557","article-title":"Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-\u03b2, IL-11, IL-17, and type I and type III collagen expression","volume":"111","author":"Chakir","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-7-135","article-title":"IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?","volume":"7","author":"Bullens","year":"2006","journal-title":"Respir Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/02770903.2020.1737710","article-title":"Elevated Th17 cell frequencies and Th17\/Treg ratio are associated with airway hyperresponsiveness in asthmatic children","volume":"58","author":"Zheng","year":"2021","journal-title":"J Asthma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1378\/chest.09-3058","article-title":"Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD","volume":"138","author":"Doe","year":"2010","journal-title":"Chest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.rmed.2010.02.018","article-title":"Increased serum IL-17 is an independent risk factor for severe asthma","volume":"104","author":"Agache","year":"2010","journal-title":"Respir Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaci.2016.10.034","article-title":"Identification of IL-17F\/frequent exacerbator endotype in asthma","volume":"140","author":"Ricciardolo","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1900068","DOI":"10.1183\/13993003.00068-2019","article-title":"Elevated serum IgE, oral corticosteroid dependence and IL-17\/22 expression in highly neutrophilic asthma","volume":"54","author":"Bullone","year":"2019","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1900588","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a european respiratory society\/american thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","article-title":"TH17-associated cytokines (IL-17A and IL-17F) in severe asthma","volume":"123","author":"Al-Ramli","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4161\/auto.24039","article-title":"Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells","volume":"9","author":"Liu","year":"2013","journal-title":"Autophagy."},{"key":"B20","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.4049\/jimmunol.182.3.1631","article-title":"The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation","volume":"182","author":"Swaidani","year":"2009","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1006175","DOI":"10.1371\/journal.ppat.1006175","article-title":"Central role of IL-23 and IL-17 producing eosinophils as immunomodulatory effector cells in acute pulmonary aspergillosis and allergic asthma","volume":"13","author":"Guerra","year":"2017","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11882-020-00903-x","article-title":"Th17\/IL-17 axis regulated by airway microbes get involved in the development of asthma","volume":"20","author":"Liu","year":"2020","journal-title":"Curr Allergy Asthma Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.4049\/jimmunol.176.9.5652","article-title":"STAT3 and NF-\u03baB Signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice","volume":"176","author":"Cho","year":"2006","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Autocrine IL-17A-IL-17RC neutrophil activation in fungal infections is regulated by IL-6, IL-23, ROR\u03b3t and Dectin-2 HHS Public Access","volume":"15","author":"Taylor","year":"2014","journal-title":"Nat Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1634\/stemcells.21-6-661","article-title":"The profile of gene expression of human marrow mesenchymal stem cells","volume":"21","author":"Silva","year":"2003","journal-title":"Stem Cells."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor\u2013based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1165\/rcmb.2015-0038OC","article-title":"IL-17RA signaling in airway inflammation and bronchial hyperreactivity in allergic asthma","volume":"53","author":"Willis","year":"2015","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma-present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1602135","DOI":"10.1183\/13993003.02135-2016","article-title":"T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED","volume":"49","author":"Kuo","year":"2017","journal-title":"Eur Respir J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Toward clinically applicable biomarkers for asthma: an EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaci.2018.12.1020","article-title":"A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma","volume":"144","author":"Fricker","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","article-title":"T H 17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice","volume":"181","author":"McKinley","year":"2008","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ni.1926","article-title":"Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma","volume":"11","author":"Lajoie","year":"2010","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jaci.2010.11.043","article-title":"Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production","volume":"127","author":"Newcomb","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.bbrc.2017.11.207","article-title":"IL-13 regulates IL-17C expression by suppressing NF-\u03baB-mediated transcriptional activation in airway epithelial cells","volume":"495","author":"Yamanaka","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1084\/jem.20061401","article-title":"Interleukin-17 is a negative regulator of established allergic asthma","volume":"203","author":"Schnyder-Candrian","year":"2006","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jaci.2019.03.027","article-title":"IL-17\u2013high asthma with features of a psoriasis immunophenotype","volume":"144","author":"\u00d6stling","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cea.13301","article-title":"Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2\/Th17 high asthma","volume":"49","author":"Kim","year":"2019","journal-title":"Clin Exp Allergy."},{"key":"B46","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI123524","article-title":"HSP90 inhibitor geldanamycin reverts IL-13\u2013and IL-17\u2013induced airway goblet cell metaplasia","volume":"129","author":"Pezzulo","year":"2019","journal-title":"J Clin Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41590-020-0777-3","article-title":"A regulatory T cell Notch4\u2013GDF15 axis licenses tissue inflammation in asthma","volume":"21","author":"Harb","year":"2020","journal-title":"Nat Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.iac.2018.06.005","article-title":"The role of neutrophils in asthma","volume":"38","author":"Panettieri","year":"2018","journal-title":"Immunol Allergy Clin North Am."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cea.13378","article-title":"Severe asthma-A population study perspective","volume":"49","author":"Backman","year":"2019","journal-title":"Clin Exp Allergy."},{"key":"B52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/thoraxjnl-2011-200160","article-title":"Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma","volume":"67","author":"Essilfie","year":"2012","journal-title":"Thorax."},{"key":"B54","doi-asserted-by":"publisher","first-page":"24898","DOI":"10.18632\/oncotarget.24653","article-title":"Long-term exposure to low-dose Haemophilus influenzae during allergic airway disease drives a steroid-resistant neutrophilic inflammation and promotes airway remodeling","volume":"9","author":"Yang","year":"2018","journal-title":"Oncotarget."},{"key":"B55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaci.2017.03.044","article-title":"Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology","volume":"141","author":"Taylor","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12931-015-0207-5","article-title":"TWEAK enhances TGF-\u03b2-induced epithelial-mesenchymal transition in human bronchial epithelial cells","volume":"16","author":"Itoigawa","year":"2015","journal-title":"Respir Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12890-020-1057-6","article-title":"Cigarette and IL-17A synergistically induce bronchial epithelial-mesenchymal transition via activating IL-17R\/NF-\u03baB signaling","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Pulm Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"L843","DOI":"10.1152\/ajplung.00416.2018","article-title":"Regulation of IL-17A and implications for TGF-\u03b21 comodulation of airway smooth muscle remodeling in severe asthma","volume":"316","author":"Evasovic","year":"2019","journal-title":"Am J Physiol - Lung Cell Mol Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/cea.12744","article-title":"Human bronchial and parenchymal fibroblasts display differences in basal inflammatory phenotype and response to IL-17A","volume":"46","author":"Dessalle","year":"2016","journal-title":"Clin Exp Allergy."},{"key":"B61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12931-016-0482-9","article-title":"Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study","volume":"17","author":"Loza","year":"2016","journal-title":"Respir Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"963","DOI":"10.4049\/jimmunol.1501531","article-title":"Molecular mechanisms of airway hyperresponsiveness in a murine model of steroid-resistant airway inflammation","volume":"196","author":"Manni","year":"2016","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1183\/09031936.00112606","article-title":"Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma","volume":"29","author":"An","year":"2007","journal-title":"Eur Respir J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1183\/09031936.00146905","article-title":"Clinical relevance of airway remodelling in airway diseases","volume":"30","author":"James","year":"2007","journal-title":"Eur Respir J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","article-title":"Remodeling in asthma and chronic obstructive lung disease","volume":"164","author":"Jeffery","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B66","first-page":"589","article-title":"The functional consequences of airway remodelling in asthma","volume":"52","author":"Par\u00e9","year":"1997","journal-title":"Monaldi Arch Chest Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jaci.2016.04.037","article-title":"IL-17A enhances IL-13 activity by enhancing IL-13\u2013induced signal transducer and activator of transcription 6 activation","volume":"139","author":"Hall","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1165\/rcmb.2014-0429OC","article-title":"Influence of an allergen-specific Th17 response on remodeling of the airways","volume":"54","author":"Peters","year":"2016","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.4049\/jimmunol.0900614","article-title":"Regulation of airway MUC5AC expression by IL-1\u03b2 and IL-17A; the NF-\u03baB paradigm","volume":"183","author":"Fujisawa","year":"2009","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1301360","article-title":"T Cell\u2013derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia","volume":"191","author":"Fogli","year":"2013","journal-title":"J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.chest.2017.10.031","article-title":"HDAC2 suppresses IL17A-mediated airway remodeling in human and experimental modeling of COPD","volume":"153","author":"Lai","year":"2018","journal-title":"Chest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol - Lung Cell Mol Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jaci.2010.12.1117","article-title":"TH17 cytokines induce human airway smooth muscle cell migration","volume":"127","author":"Chang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1096\/fj.12-208033","article-title":"Th17-associated cytokines promote human airway smooth muscle cell proliferation","volume":"26","author":"Chang","year":"2012","journal-title":"FASEB J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","article-title":"Update on glucocorticoid action and resistance","volume":"117","author":"Ito","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"190096","DOI":"10.1183\/16000617.0096-2019","article-title":"Cellular mechanisms underlying steroid-resistant asthma","volume":"28","author":"Wadhwa","year":"2019","journal-title":"Eur Respir Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1165\/rcmb.2008-0028OC","article-title":"Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma","volume":"39","author":"Ito","year":"2008","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jaci.2014.05.038","article-title":"Increased frequency of dual-positive TH2\/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma","volume":"134","author":"Irvin","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1183\/09031936.00017911","article-title":"Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells","volume":"39","author":"Zijlstra","year":"2012","journal-title":"Eur Respir J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/j.1365-2222.2010.03544.x","article-title":"Induction of glucocorticoid receptor-\u03b2 expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines","volume":"40","author":"Vazquez-Tello","year":"2010","journal-title":"Clin Exp Allergy."},{"key":"B83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11882-007-0005-3","article-title":"Alpha and beta glucocorticoid receptors: relevance in airway diseases","volume":"7","author":"Pujols","year":"2007","journal-title":"Curr Allergy Asthma Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10875-012-9828-3","article-title":"Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells","volume":"33","author":"Vazquez-Tello","year":"2013","journal-title":"J Clin Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jaci.2011.12.001","article-title":"Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients","volume":"129","author":"Goleva","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2015.01.026","article-title":"Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-\u03b3high immunophenotypes: potential benefits of calcitriol","volume":"136","author":"Chambers","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e132836","DOI":"10.1172\/jci.insight.132836","article-title":"Targeting IL-17A\/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases","volume":"5","author":"Ouyang","year":"2020","journal-title":"JCI Insight."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1801444","DOI":"10.1183\/13993003.01444-2018","article-title":"Randomised controlled trials in severe asthma: selection by phenotype or stereotype","volume":"52","author":"Brown","year":"2018","journal-title":"Eur Respir J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1398-9995.2009.02282.x","article-title":"Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children","volume":"65","author":"Snijders","year":"2010","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0091-6749(91)90160-P","article-title":"Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronc","volume":"88","author":"Bradley","year":"1991","journal-title":"J Allergy Clin Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"ii43","DOI":"10.1093\/rheumatology\/kew346","article-title":"Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases","volume":"55","author":"Nirula","year":"2016","journal-title":"Rheumatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1517\/14712598.2015.1045410","article-title":"Brodalumab-An IL-17RA monoclonal antibody for psoriasis and psoriatic arthritis","volume":"15","author":"Bauer","year":"2015","journal-title":"Expert Opin Biol Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/all.14221","article-title":"Efficacy and safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI guidelines\u2014Recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/JAA.S275068","article-title":"Dupilumab efficacy in patients stratified by baseline treatment intensity and lung function","volume":"13","author":"Pavord","year":"2020","journal-title":"J Asthma Allergy."},{"key":"B101","doi-asserted-by":"publisher","first-page":"107026","DOI":"10.1016\/j.intimp.2020.107026","article-title":"Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway","volume":"89","author":"\u00c1lvarez-Coiradas","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrd1343","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing towards the dream","volume":"3","author":"Arkin","year":"2004","journal-title":"Nat Rev Drug Discov."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1021\/acs.jmedchem.5b01693","article-title":"A binding site on IL-17A for inhibitory macrocycles revealed by hydrogen\/deuterium exchange mass spectrometry","volume":"59","author":"Espada","year":"2016","journal-title":"J Med Chem."},{"key":"B104","doi-asserted-by":"publisher","first-page":"eaaf8823","DOI":"10.1126\/scisignal.aaf8823","article-title":"The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo","volume":"10","author":"Liu","year":"2017","journal-title":"Sci Signal"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.694514\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T15:17:39Z","timestamp":1673191059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2021.694514\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":104,"alternative-id":["10.3389\/falgy.2021.694514"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2021.694514","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"article-number":"694514"}}